Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2008 6
2009 2
2010 2
2011 5
2012 1
2014 3
2015 5
2016 1
2017 1
2020 4
2021 4
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation.
Gregorio C, Spreafico M, D'Amico S, Sauta E, Asti G, Lanino L, Tentori CA, Platzbecker U, Haferlach T, Diez-Campelo M, Fenaux P, Komrokji R, Della Porta MG, Ieva F. Gregorio C, et al. Among authors: spreafico m. JCO Clin Cancer Inform. 2024 May;8:e2300205. doi: 10.1200/CCI.23.00205. JCO Clin Cancer Inform. 2024. PMID: 38723213 Free article.
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
Tentori CA, Gregorio C, Robin M, Gagelmann N, Gurnari C, Ball S, Caballero Berrocal JC, Lanino L, D'Amico S, Spreafico M, Maggioni G, Travaglino E, Sauta E, Meggendorfer M, Zhao LP, Campagna A; GenoMed4All, Synthema, GESMD, FISIM, and EuroBloodNET; Savevski V, Santoro A, Al Ali N, Sallman D, Sole F, Garcia-Manero G, Germing U, Kroger N, Kordasti S, Santini V, Sanz G, Kern W, Platzbecker U, Diez-Campelo M, Maciejewski JP, Ades L, Fenaux P, Haferlach T, Zeidan AM, Castellani G, Komrokji R, Ieva F, Della Porta MG. Tentori CA, et al. Among authors: spreafico m. J Clin Oncol. 2024 May 9:JCO2302175. doi: 10.1200/JCO.23.02175. Online ahead of print. J Clin Oncol. 2024. PMID: 38723212
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I, Agosti P, Boscarino M, Ferrari B, Artoni A, Palla R, Spreafico M, Crovetti G, Volpato E, Rossini S, Novelli C, Gattillo S, Barcella L, Salmoiraghi M, Falanga A, Peyvandi F; Lombardy AREU TMA Network. Mancini I, et al. Orphanet J Rare Dis. 2022 Jun 23;17(1):246. doi: 10.1186/s13023-022-02400-y. Orphanet J Rare Dis. 2022. PMID: 35739601 Free PMC article.
Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma.
Spreafico M, Ieva F, Arlati F, Capello F, Fatone F, Fedeli F, Genalti G, Anninga J, Gelderblom H, Fiocco M. Spreafico M, et al. BMJ Open. 2021 Dec 16;11(12):e053456. doi: 10.1136/bmjopen-2021-053456. BMJ Open. 2021. PMID: 34916320 Free PMC article. Clinical Trial.
Black blood matters.
Berzuini A, Foglieni B, Spreafico M, Gerosa A, Revelli N, Paccapelo C, Prati D. Berzuini A, et al. Among authors: spreafico m. Blood Transfus. 2021 Sep;19(5):363-365. doi: 10.2450/2021.0144-21. Epub 2021 Jul 20. Blood Transfus. 2021. PMID: 34369866 Free PMC article. No abstract available.
37 results